<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig4">
 <label>Fig. 4</label>
 <caption>
  <p>SARS-CoV-2, Main proteinase 3CL
   <sup>pro</sup> analysis. 
   <bold>a</bold> Cartoon representation structure of the SARS-CoV-2 3CL
   <sup>pro</sup> homodimer with inhibitor (green) in greyish black colour. Variant positions of amino acids in 3CL
   <sup>pro</sup> (Thr35Val, Ala46Ser, Ser65Asn, Leu86Val, Arg88Lys, Ser94Ala, His134Phe, Lys180Asn, Leu202Val, Ala267Ser, Thr285Ala and Ile286Leu) are shown in yellow colours. 
   <bold>b</bold> Multiple sequence alignment between SARS-CoV and SARS-CoV-2 3CL
   <sup>pro</sup> from Wuhan (Wu) and United States of America (US) patients sharing more than 90% sequence identity. 
   <bold>c</bold> Surface view representation of SARS-CoV-2 3CL
   <sup>pro</sup> (PDB ID: 6Y2G) showing muted amino acid residues in yellow and alpha-ketoamide inhibitor (green) in the substrate binding region. Images are generated by UCSF Chimera software
  </p>
 </caption>
 <graphic xlink:href="12967_2020_2448_Fig4_HTML" id="MO4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
